Franklin Resources
AKBA icon

Franklin Resources’s Akebia Therapeutics AKBA Stock Holding History

Franklin Resources’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
251,014
+213,713
+573% +$254K ﹤0.01% 2736
2026
Q1 		$51.8K Sell
37,301
-144,318
-79% -$198K ﹤0.01% 3004
2025
Q4 		$292K Sell
181,619
-2,498,569
-93% -$5.23M ﹤0.01% 2636
2025
Q3 		$7.32M Buy
2,680,188
+12,776
+0.5% +$42.5K ﹤0.01% 1274
2025
Q2 		$9.71M Buy
2,667,412
+85
+0% +$234 ﹤0.01% 1145
2025
Q1 		$5.12M Buy
2,667,327
+2,500,143
+1,495% +$5.1M ﹤0.01% 1338
2024
Q4 		$318K Hold
167,184
– – ﹤0.01% 2482
2024
Q3 		$221K Buy
+167,184
New +$223K ﹤0.01% 2608
2024
Q1 		– Sell
-65,083
Closed -$80.7K – 2862
2023
Q4 		$80.7K Hold
65,083
– – ﹤0.01% 2494
2023
Q3 		$74.2K Sell
65,083
-17,390
-21% -$22.3K ﹤0.01% 2491
2023
Q2 		$75.5K Hold
82,473
– – ﹤0.01% 2571
2023
Q1 		$46.2K Hold
82,473
– – ﹤0.01% 2195
2022
Q4 		$47.6K Hold
82,473
– – ﹤0.01% 2220
2022
Q3 		$26K Hold
82,473
– – ﹤0.01% 2243
2022
Q2 		$29K Sell
82,473
-39,922
-33% -$16.8K ﹤0.01% 2286
2022
Q1 		$88K Buy
122,395
+697
+0.6% +$1.49K ﹤0.01% 2315
2021
Q4 		$275K Sell
121,698
-302
-0.2% -$823 ﹤0.01% 2116
2021
Q3 		$351K Buy
+122,000
New +$348K ﹤0.01% 2030
2015
Q1 		– Sell
-86,500
Closed -$1.01M – 1582
2014
Q4 		$1.01M Sell
86,500
-335,000
-79% -$4.8M ﹤0.01% 1388
2014
Q3 		$9.33M Sell
421,500
-88,900
-17% -$2.04M ﹤0.01% 1053
2014
Q2 		$14.2M Buy
+510,400
New +$12.3M 0.01% 968

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources's AKBA Position: Q2 2026 in Review

Franklin Resources increased its Akebia Therapeutics (AKBA) stake by 573% in Q2 2026, buying an estimated $254K and bringing the position to 251,014 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Franklin Resources first reported a position in AKBA in Q2 2014 and has held it in 21 quarters since. The position peaked at $14.2M in Q2 2014. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Franklin Resources held 251,014 shares of Akebia Therapeutics worth $286K as of Q2 2026.
  • Franklin Resources bought 213,713 Akebia Therapeutics shares in Q2 2026, an estimated $254K.
  • Akebia Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2736 holding.
  • Franklin Resources first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 21 quarters since.
  • Franklin Resources's Akebia Therapeutics position peaked at $14.2M in Q2 2014.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.